Curis, Inc
Link ID 246358
Title Curis, Inc
Url http://www.curis.com/
Description Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)
Category Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
Keywords
Date Jul 19, 2006
Contact Name
Email
Add to My Favorite   Refer it to Friend   Report Broken Link  


 Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
1. Archemix Corp.
  Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


2. Xoma
  Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


3. Avigen, Inc.
  Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


4. Maxygen, Inc.
  Develops proprietary protein modifications including PEG, glycosylation and vaccines. Overview of technologies, clinical trial pipeline, investor data and careers in Redwood City, California. (Nasdaq: MAXY)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


5. Rib-X Pharmaceuticals Inc.
  Structure-based drug design start-up, specializing in the ribosome as a target, and bacterial antibiotic resistance. Includes mechanisms of action, glossary, careers, corporate news and contacts and directions in New Haven, Connecticut.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development




Home      New Listings      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing     Disclaimer
Copyright © internet-directory.com 1999-2023

Sponsors